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Abstract
Agaricus blazei Murill (AbM) has been reported to possess immune activity against tumors and infections through
stimulation of mononuclear phagocytes. Recently, AbM extract was shown to induce the production of the pro-
inflammatory cytokine, interleukin-1b (IL-1b), in human monocytes. IL-1b is a key pro-inflammatory cytokine produced by
activated macrophages and monocytes and its secretion is strictly controlled by the inflammasome. The purpose of this
study is to investigate the effect of AbM water extracts on the regulation of IL-1b production and activation of the NLRP3
inflammasome in human THP-1 macrophages. The NLRP3 inflammasome consists of an NLRP3 receptor, an adaptor protein
called ASC, and the inflammatory protease, caspase-1. Typically, stimulation of immune cells with microbial products results
in production of pro-IL-1b, but a second stress-related signal activates the inflammasome and caspase-1, leading to
processing and secretion of IL-1b. Our results show that AbM enhances transcription of IL-1b and triggers NLRP3
inflammasome-mediated IL-1b secretion in human THP-1 macrophages. AbM-mediated IL-1b secretion was markedly
reduced in macrophages deficient in NLRP3 and ASC, demonstrating that the NLRP3 inflammasome is essential for AbM-
induced IL-1b secretion. In addition, caspase-1 was activated and involved in proteolytic cleavage and secretion of IL-1b in
AbM-treated macrophages. AbM-mediated IL-1b secretion also decreased in cells treated with cathepsin B inhibitor,
suggesting that AbM can induce the release of cathepsin B. Furthermore, our data show that AbM-induced inflammasome
activation requires the release of ATP, binding of extracellular ATP to the purinergic receptor P2X7, the generation of
reactive oxygen species, and efflux of potassium. Taken together, these findings reveal that AbM activates the NLRP3
inflammasome via multiple mechanisms, resulting in the secretion of IL-1b.
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Introduction
The medicinal mushroom Agaricus blazei Murill (AbM), a
member of the Basidiomycetes family, is an edible mushroom that
grows wildly in the coastal Piedade area of São Paulo, Brazil. It has
recently received great attention in folk medicine due to its use in
the prevention of a variety of diseases, including cancer, chronic
hepatitis, diabetes, arteriosclerosis and hyperlipidaemia [1].
Agaricus blazei Murill is particularly rich in proteoglucans and
different forms of b-glucans, such as b (1,3)-, b (1,4)- and b(1,6)-D-
glucans [2,3]. These b-glucans exhibit potent anti-tumor activity
in mouse models and cancer cell cultures [4–6], and have
immunomodulatory effects on monocytes, macrophages and NK
cells [7–9]. Other reports found b-glucans from yeast and fungus
also can protect host against certain types of bacterial infections in
mice; these microorganisms include Mycobacterium bovis [10] and
Streptococcus pneumonia [11]. An extensive study by Bernardshaw et
al., (2005) showed that treatment with water-extracted AbM
decreased bacteraemia and thereby increased the survival rate of
mice when the mice were intraperitoneally infected with
Streptococcus pneumonia serotype 6B [12].
Another study by Bernardshaw et al., (2005) showed that AbM
induced dose-dependent production of pro-inflammatory cyto-
kines, including IL-1b and IL-6, in human monocytes and
umbilical vein endothelial cells [13]. The stimulatory effect of
AbM-based extract (AndoSanTM) on cytokine production (IL-1b,
IL-6, IL-8, TNF-a, G-CSF and MIP-1b) in monocyte-derived
dendritic cells (MDDC) was further demonstrated by Førland et
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al., (2010) [14]. Based on the results of gene expression microarray
analysis of human monocytic THP-1 cells, Ellertsen et al., (2006)
found that AbM extract strongly induced upregulation of genes for
IL-1b and IL-8, but not for IL-10 and IL-12 [15]. Agaricus
brasiliensis ( = blazei) extract was also found to induce mRNA
expressions of TNF-a, IL-1b, and COX-2 in PMA differentiated
THP-1 cells [16].
IL-1b is a key pro-inflammatory mediator crucial for local and
systemic inflammation [17]. This cytokine is mainly produced by
the blood monocyte, tissue macrophages and dendritic cells. B
lymphocytes and NK cells can also produce IL-1b [17]. This
cytokine participates in the generation of systemic and local
immune responses against various strains of pathogens, and it has
been implicated in the pathogenesis of inflammatory diseases, such
as gout, asthma, inflammatory bowel diseases (IBDs), rheumatoid
arthritis (RA), and atherosclerosis [18–20].
NLRP3 (also known as NALP3, cryopyrin, CIAS1, or
PYPAF1), a member of the NOD-like receptor (NLR) family,
was recently shown to form a cytoplasmic complex known as the
NLRP3 inflammasome, which is the most fully characterized
inflammasome and is responsible for activation of caspase-1 (also
known as IL-1b-converting enzyme or ICE) by a vast number of
pathogens and stress- or damage-related stimuli [21,22]. Upon
activation, NLRP3 recruits an adaptor, apoptosis-associated speck-
like protein (ASC) containing a C-terminal caspase recruitment
domain (CARD), which in turn, recruits procaspase-1 to form a
multi-protein complex leading to the activation of caspase-1 via
autoprocessing [23,24]. Caspase-1 activation is required for
proteolytic cleavage of pro-IL-1b, leading to the secretion of
biologically active IL-1b [25]. The NLRP3 inflammasome has
been also shown to be activated by endogenous or exogenous
stimuli, such as ATP, monosodium urate (MSU) crystals,
cholesterol crystals, UVB irradiation, pathogen-derived nucleic
acids, silica, asbestos, and amyloid-b [26–34]. A broad array of
mediators have been reported to activate the NLRP3 inflamma-
some. Thus, elevated reactive oxygen species (ROS) levels,
depletion of intracellular potassium (K+), disruption of lysosomal
membrane leading to the release of the cysteine protease cathepsin
B, and apoptosis can modulate NLRP3 inflammasome activation
[26,30,35,36]. In addition, the NLRP3 inflammasome can be
activated by the ‘‘danger signal’’, extracellular ATP, through
stimulation of the purinergic P2X7 receptor (P2X7R), which serves
as an ATP-gated cation channel and rapidly causes collapse of
ionic gradients by allowing K+ efflux [31,37,38].
Water extracts of AbM were previously shown to induce the
production of cytokine IL-1b in human monocytic THP-1 cells;
however, the molecular basis of IL-1b was not characterized. The
aim of this study is therefore to investigate whether AbM
stimulation of IL-1b secretion in macrophages involves caspase-1
or inflammasome activation. In the present report, we demon-
strate that incubation of THP-1 macrophages with AbM extracts
results in NLRP3 inflammasome-dependent activation of caspase-
1 and secretion of mature IL-1b. We also investigated the
molecular mechanisms involved in inflammasome and caspase-1
activation. Taken together, we found that the NLRP3 inflamma-
some plays an important role in regulating AbM-induced IL-1b
secretion via multiple mechanisms.
Results
AbM extract activates pro-IL-1b expression and induces
the secretion of IL-1b in human THP-1 macrophages
The effects of AbM extract on the viability of human THP-1
macrophages were first studied. THP-1 macrophages were treated
with AbM extract at concentrations increasing from 0.1 to 5% for
24 h at 37uC. After 24 h of incubation, the viability of THP-1
macrophages was assessed by the MTT assay. As compared to
untreated control cells, the cell viability of THP-1 macrophages
was slightly reduced by treatment with higher concentrations of
AbM extract (Fig. 1). In addition, no striking morphological
changes in the macrophages were observed during the course of
this experiment.
AbM extract was further examined for its ability to induce the
synthesis or causing the secretion of IL-1b. The macrophages were
therefore treated with increasing concentrations of AbM extract
for 24 h. After AbM treatment, the cells were collected and
mRNA expression levels of IL-1b were analyzed by RT-PCR. The
AbM extract can strongly induce expression of the IL-1b gene
(Figs. 2A and 2B).
The ELISA assay was used for analyzing whether AbM extract
can induce secretion of the mature form of IL-b from
macrophages. Thus, the cells were treated with AbM extract
(0.1–5%) for 24 h, and IL-1b was measured in the cell culture
supernatants. The results show that AbM extract induced dose-
dependent secretion of mature IL-1b (Fig. 2C). In order to confirm
the production and processing of pro-IL-1b in the cells and also
verify the secretion of mature IL-1b into the cell culture
supernatants, cells treated with the AbM extract for 24 h were
characterized by Western blot analysis. AbM extract enhanced
proteolytic cleavage of pro-IL-1b in the cells and also induced the
appearance of mature IL-1b in the cell culture supernatants
(Fig. 2D). These data show that AbM extract triggers both the
transcription and the secretion of IL-1b in human THP-1
macrophages.
The secretion of IL-1b induced by AbM extract is caspase-
1 dependent
Inflammasome activation results in the recruitment and
activation of caspase-1. Caspase-1 is the key enzyme involved in
the processing of pro-IL-1b to form the biologically active IL-1b
[39]. To characterize the activation of caspase-1, cells were treated
with AbM extract for 24 h, and the presence of the inactive
procaspase-1 and activated caspase-1 (p20) was measured in cell
lysates by Western blot analysis. As shown in Fig. 3A, AbM extract
enhanced the formation of caspase-1 p20 in human macrophages.
Figure 1. Absence of toxicity of the AbM extract on THP-1
macrophages. Cells were treated with AbM at concentrations of 0.1–
5% for 24 h. Cell viability was measured by MTT assays, as described in
Materials and Methods. Data are presented as means 6 SE of 3
experiments preformed in duplicate.
doi:10.1371/journal.pone.0041383.g001
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This result was confirmed by measuring the presence of caspase-1
p20 subunits secreted into the supernatants of the AbM-treated
macrophages, as detected by ELISA (Fig. 3B). The secretion of
activated caspase-1 was significantly increased in the supernatants
of the AbM-stimulated macrophages, indicating that AbM extract
can induce the proteolytic processing of caspase-1.
In order to determine whether AbM-induced IL-1b secretion
required caspase-1-mediated processing of pro-IL-1b, the macro-
phages were pretreated for 30 min with a specific caspase-1
inhibitor (Z-YVAD-fmk) and, subsequently, were treated with the
AbM extract. The protein expression of procaspase-1 and caspase-
1 in caspase-1 inhibitor-treated macrophages was determined by
Western blot analysis. Caspase-1 activation was reduced dramat-
ically in the caspase-1 inhibitor-treated cells as seen in Fig. 3C. IL-
1b secretion induced by AbM extract was also significantly
decreased when macrophages were pretreated with caspase-1
inhibitor (Fig. 3D). Thus, we conclude that IL-1b secretion of by
AbM extract is mediated through caspase-1activation.
AbM-induced secretion of IL-1b is dependent upon the
NLRP3 inflammasome
The NLRP3 inflammasome consists of the NLRP3 receptor and
an adaptor ASC, which are required for caspase-1 activation. To
evaluate whether the AbM extract can activate the NLRP3
inflammasome, the role of either NLRP3 or ASC was determined
by gene silencing experiments with NLRP3 or ASC shRNA in the
human THP-1 macrophages. The mRNA expression level of
inflammasome components was significantly reduced in compar-
ison with nontarget shRNA, which was measured by RT-PCR
(Fig. 4A). Protein depletion was also determined by Western blot
analysis (Fig. 4B). The ELISA assay and Western blot analysis
showed that depletion of either NLRP3 or ASC led to a significant
decrease of IL-1b secretion and processing after 24 h treatment of
macrophages with AbM extract (Figs. 4C and 4D). Taken
together, these results demonstrate that the NLRP3 inflammasome
is required for optimal AbM-induced IL-1b secretion.
Inhibition of cathepsin B decreases AbM-induced
secretion of IL-1b
Phagocytosis of MSU, silica crystals, aluminum salts, or fibrillar
amyloid-b has been shown to induce lysosomal damage and the
release of cathepsin B into the cytosol, leading to activation of the
NLRP3 inflammasome and IL-1b secretion [30,40]. Since Hentze
et al., (2003) and Vancompernolle et al., (1998), had also shown
that the lysosomal protease cathepsin B can activate caspase-1
[41,42], we evaluated whether AbM-induced IL-1b secretion is
Figure 2. AbM extract induced secretion of IL-1b in THP-1 macrophages. (A) THP-1 cells were incubated with AbM at concentrations of 0.1–
5% for 24 h. The mRNA expression levels of IL-1b were determined by RT-PCR analysis. (B) The intensity of the bands was densitometrically measured
and normalized to the mRNA expression level of b-actin gene. (C) Cell culture supernatants were collected and assayed for IL-1b secretion by ELISA.
(D) The presence of IL-1b in cell lysates and cell culture supernatants were analyzed by Western blot analysis. Data are presented as means 6 SE of 3
experiments preformed in duplicate. *P,0.05 versus untreated cells.
doi:10.1371/journal.pone.0041383.g002
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dependent on cathepsin B. Thus, THP-1 macrophages were either
untreated (control) or pretreated with cathepsin B inhibitor
(10 mM CA-074-Me) for 30 min and, subsequently, treated with
AbM extract at concentrations of 0.1–5% for 24 h. As seen in
Fig. 5A, inhibition of cathepsin B with CA-074-Me leads to a
partial but significant reduction of AbM-induced IL-1b release,
implying that the effect of AbM treatment is mediated at least
partially by lysosomal disruption.
Potassium efflux contributes to AbM-induced IL-1b
secretion
Lowering the intracellular concentration of potassium (K+) is
crucial for activation of the NLRP3 inflammasome in response to
a variety of stimuli [35]. In order to examine whether K+ efflux
affects AbM-induced IL-1b secretion, THP-1 macrophages were
untreated or pretreated with extracellular KCl at concentrations of
either 1 mM or 5 mM for 30 min and, subsequently, treated with
AbM extract at concentrations of 0.1–5% for 24 h. As seen in
Fig. 5B, increasing the extracellular KCl concentration could
significantly reduce AbM-induced IL-1b secretion. Our results
thus suggest that K+ efflux is needed for AbM-mediated NLRP3
inflammasome activation in macrophages.
Inhibition of reactive oxygen species (ROS) decreases
AbM-induced secretion of IL-1b
ATP and particulate activators such as asbestos and silica have
been shown to trigger ROS production. The ROS production was
required for downstream NLRP3 inflammasome-dependent
caspase-1 activation [26,43,44]. Based on these previous studies,
we first measured ROS production in THP-1 macrophages after
exposure to AbM extract at concentrations of 0.1–5% using a
commercially available ROS detection kit. A dose-dependent
relationship was observed when ROS production in THP-1
macrophages was increased as increment in AbM concentration
(Fig. 6A). We also analyzed whether ROS production was
required for AbM-induced IL-1b secretion. THP-1 macrophages
were untreated or pretreated with ROS inhibitors-APDC (50 mM)
or BHA (10 mM) for 30 min and, subsequently, treated with AbM
extract at concentrations of 0.1–5% for 24 h. As shown in Fig. 6B,
the ROS inhibitors significantly reduced AbM-mediated IL-1b
Figure 3. AbM extract induced caspase-1 activation in THP-1 macrophages. (A) and (C) Procaspase-1 p45 and caspase-1 subunit p20 were
detected in cell lysates by Western blot analysis. (B) The secretion of the caspase-1 subunit p20 into the supernatants of THP-1 cells treated with AbM
at concentrations of 0.1–5% for 24 h was assessed by ELISA. (D) THP-1 macrophages were untreated or pretreated for 30 min with the caspase-1
inhibitor, Z-YVAD-fmk (20 mM). Subsequently, cells were incubated with AbM at concentrations of 0.1–5% for 24 h, and IL-1b production was
measured by ELISA. Data are presented as means 6 SE of 3 experiments preformed in duplicate. *P,0.05 versus AbM-untreated control cells.
#P,0.05 versus caspase-1 inhibitor-treated cells.
doi:10.1371/journal.pone.0041383.g003
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secretion in macrophages. These results suggest that AbM
stimulates production of physiological levels of ROS, which result
in IL-1b secretion.
The release of ATP and binding of ATP to P2X7 are
involved in AbM-induced IL-1b secretion
Ligation of the purinergic receptor P2X7 by extracellular ATP
can stimulate NLRP3 inflammasome and caspase-1 activation the
secretion of IL-1b [45,46]. To evaluate whether the effect of AbM
on IL-1b secretion is mediated through P2X7, we pretreated
macrophages with the P2X7 antagonist, oxidized ATP (oATP), for
30 min, and then treated with AbM extract at concentrations of
0.1–5% for 24 h. As shown in Fig. 7A, preincubation with oATP
significantly reduced the AbM-induced secretion of IL-1b,
suggesting that P2X7R signaling is involved in AbM-induced
inflammasome activation. As this result also suggested that AbM
may stimulate ATP release from macrophages, we also determined
the possible involvement of ATP release in AbM-induced IL-1b
secretion by using apyrase, an enzyme that can rapidly hydrolyze
extracellular ATP. In fact, apyrase significantly reduced AbM-
induced IL-1b secretion in macrophages (Fig. 7B). Collectively,
these results indicate that AbM-induced IL-1b secretion is
dependent on ATP release and binding of extracellular ATP to
P2X7.
Discussion
AbM is thought to exert its effect mainly through modulation of
the immune system, and to promote strong pro-inflammatory
responses through macrophages, neutrophils and lymphocytes. In
fact, modulation of the immune system has been reported to be the
predominant mechanism behind the protective effect of AbM
against tumor development and bacterial infection in murine
models [7,12,47–49]. Previous reports have established that the
expression of IL-1b mRNA was augmented by AbM extract in
mouse peritoneal macrophages upon oral administration [50], and
that AbM extract also upregulates the genes for IL-1b and
caspase-1 in THP-1 cells [15,16]. However, the ability of AbM to
Figure 4. AbM-induced secretion of IL-1b depended upon the NLRP3 inflammasome. (A) THP-1 cells were stably transfected with shRNAs
targeting ASC and NLRP3, and mRNA expression of ASC and NLRP3 was measured by RT-PCR and compared with nontarget control (shCtrl). (B)
Knockdown cells were lysed and the protein lysates were subjected to Western blot analysis to confirm decreased protein expression of ASC and
NLRP3. b-actin served as the loading control. (C) Knockdown THP-1 cells were treated with AbM at concentrations of 0.1–5% for 24 h, and cell culture
supernatants were collected and assayed for IL-1b secretion by ELISA. (D) The cell culture supernatants were analyzed by Western blot analysis using
anti-IL-1b antibody. Data are presented as means 6 SE of 3 experiments preformed in duplicate. *shCtrl-THP-1 cells versus AbM-untreated shCtrl-
THP-1 cells (P,0.05). #shASC-THP-1 cells versus shCtrl-THP-1 cells (P,0.05). ???shNLRP3-THP-1 cells versus shCtrl-THP-1 cells (P,0.05).
doi:10.1371/journal.pone.0041383.g004
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stimulate IL-1b secretion or caspase-1 activation was not
investigated.
Proteolytic processing and the secretion of the mature IL-1b
require the activity of caspase-1, which depends on the assembly of
an inflammasome [51]. Our studies show that caspase-1 plays a
major role in AbM-induced IL-1b production by macrophages.
We further demonstrated that AbM-mediated caspase-1 activation
Figure 5. Cathepsin B and potassium efflux were required for AbM-induced inflammasome activation. Cells were untreated or
pretreated for 30 min with the cathepsin B inhibitor, CA-074-Me (10 mM) (A), or with extracellular potassium chloride (1 mM or 5 mM) (B). Cells were
then incubated with AbM at concentrations of 0.1–5% for 24 h. IL-1b production was measured by ELISA. Data are presented as means 6 SE of 3
experiments preformed in duplicate. *P,0.05 versus cathepsin B inhibitor-treated cells. #P,0.05 versus 1 mM KCl-treated cells. ???P,0.05 versus
5 mM KCl-treated cells.
doi:10.1371/journal.pone.0041383.g005
Figure 6. Inflammasome activation by AbM depended upon ROS production. (A) Cells were incubated with AbM at concentrations of 0.1–
5% for 24 h, and ROS production were measured with the total ROS detection kit that finally detected by the fluorescence microplate reader.
Pyocyanin (200 mM), a ROS inducer, induces the formation of ROS. (B) Cells were untreated or pretreated for 30 min with ROS inhibitor, APDC (50 mM)
or BHA (10 mM), and then cells were incubated with concentrations of AbM at 0.1–5% for 24 h. IL-1b production was measured by ELISA. Data are
presented as means 6 SE of 3 experiments preformed in duplicate. #P,0.05 versus untreated cells. *P,0.05 versus ROS inhibitor-treated cells.
doi:10.1371/journal.pone.0041383.g006
AbM Activates NLRP3 Inflammasome
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and IL-1b secretion are dependent on the NLRP3 inflammasome
in human macrophages.
The hallmark of NLRP3 inflammasome activation is proteolytic
cleavage of cysteine protease caspase-1. Activated caspase-1 in
turn cleaves pro-IL-1b into the mature form, IL-1b. Our results
show that AbM stimulates cleavage of both caspase-1 and IL-1b,
and that a caspase-1 inhibitor, Z-YVAD-fmk, blocks both AbM-
mediated caspase-1 activation and IL-1b processing and secretion.
In addition, silencing of NLRP3 and ASC decreased dramatically
secretion and processing of IL-1b in response to AbM treatment.
Our results show that, besides activating the inflammasome,
AbM also stimulated the transcription of IL-1b in human
macrophages. These results are consistent with previous reports
that AbM promotes the production of pro-inflammatory cytokines
(IL-1b, IL-6, IL-8 and TNF-a), without increasing synthesis of the
anti-inflammatory T-regulatory cell cytokine IL-10 or the Th1
cytokine IL-12 in human monocytes and macrophages [13,52].
Many crystalline substances, such as silica, asbestos, and MSU
crystals, have been shown to induce lysosomal destabilization and
rupture, following by the release of cathepsin B into the cytosol
and activation of the NLRP3 inflammasome [26,30,43]. A study
with curdlan (fungal b-glucan) had shown that the cathepsin B
inhibitor (CA-074-Me) or an inhibitor of phagocytosis (cytocha-
lasin D) completely abrogated curdlan-induced IL-1b secretion in
human macrophages [53]. Likewise, we observed that AbM-
dependent NLRP3 inflammasome activation required cathepsin B
activity because the cathepsin B inhibitor significantly reduced
AbM-induced secretion of IL-1b in human macrophages. How-
ever, we found that cytochalasin D did not affect AbM-induced
IL-1b secretion (data not shown), suggesting that AbM extracts,
unlike curdlan, do not need to be internalized by the macrophag-
es. Previous studies have demonstrated that extracellular ATP can
induce cathepsin B release from lysosomal following ligation of the
purinergic receptor P2X7 in both mouse bone marrow-derived
macrophages (BMDMs) and human alveolar macrophages
[54,55]. These findings suggest that cathepsin B-dependent
activation of the NLRP3 inflammasome and IL-1b secretion in
AbM-treated macrophages may not be mediated by phagocytosis,
but may instead be associated with the activation of P2X7.
Moreover, cathepsin cysteine proteases are known to play an
important role in the development of inflammatory diseases and
cardiovascular disease [56,57].
The NLRP3 inflammasome is activated by a wide variety of
stimuli, besides cathepsin B, both K+ efflux and ROS production
can activate the NLRP3 inflammasome [26,35,58]. Thus, Abdul-
Sater and coworkers demonstrated that infection by an intracel-
lular bacterial pathogen led to the efflux of intracellular K+, which
in turn, causing ROS production and caspase-1 activation in
epithelial cells [59]. Our data showed that increasing the
extracellular KCl concentration or the use of ROS inhibitors
significantly decreased AbM-induced secretion of IL-1b from
macrophages. AbM treatment had also been previously reported
to stimulate a slight but significant increase in ROS levels in
granulocytes [60]. Thus, our results suggest that AbM-induced
NLRP3 inflammasome activation in human macrophages is
associated with K+ efflux and ROS production.
Finally, we demonstrated that AbM extract may induce ATP
release from macrophages, since the ATP-hydrolyzing enzyme
apyrase significantly reduced IL-1b secretion from AbM-treated
macrophages. Pretreatment of macrophages with the P2X7
antagonist, oxidized ATP, also resulted in a significantly inhibition
of IL-1b secretion. A previous study had shown that the
extracellular release of endogenous ATP from human monocytes
was an early step in the activation of the inflammasome induced
by a number of pathogen- or danger-associated molecular
patterns, including muramyl dipeptide (MDP) and MSU [61]. In
addition, ATP treatment can induce the production of ROS,
which leads to activation of caspase-1 and the secretion of IL-1b
from rat alveolar macrophages [44]. In mouse BMDMs, caspase-1
activation and IL-1b secretion were induced by the addition of
Figure 7. Inflammasome activation by AbM depended upon ATP release and P2X7R ligation. Cells were untreated or pretreated for
30 min with the P2X7 antagonist, oATP (250 mM) (A), or the extracellular ATP-hydrolyzing enzyme, apyrase (1 U/ml) (B); and cells were then
incubated with AbM at concentrations of 0.1–5% for 24 h. IL-1b production was measured by ELISA. Data are presented as means 6 SE of 3
experiments preformed in duplicate. *P,0.05 versus oATP inhibitor-treated cells. #P,0.05 versus apyrase-treated cells.
doi:10.1371/journal.pone.0041383.g007
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exogenous ATP, which activated the P2X7R [58]. The role of the
P2X7R in mediating caspase-1 activation was also demonstrated
by the inability of peritoneal macrophages from P2X7R-deficient
mice to generate mature IL-1b in response to ATP [62]. These
observations suggest that AbM extract treatment may stimulate
the release of ATP, which activates the P2X7R through an
autocrine loop, promoting inflammasome activation and IL-1b
secretion.
In conclusion, our results demonstrated that AbM activated the
NLRP3 inflammasome, causing caspase-1-dependent IL-1b se-
cretion in human macrophages (Fig. 8). AbM-induced IL-1b
secretion also depended upon ATP release, binding of extracel-
lular ATP to the P2X7R, the release of active cathepsin B from
lysosomes, K+ efflux, and ROS production. The production and
secretion of pro-inflammatory cytokine IL-1b is crucial for
stimulating innate immune responses and recruiting the phago-
cytic cells to defend against tumors and bacterial infection.
Therefore, the findings of this study suggest that previous effects of
AbM that were observed against tumors and infection may be
attributed to the ability of AbM to both enhance IL-1b




Apyrase, butylated hydroxyanisole (BHA), DMSO, potassium
chloride (KCl), oxidized ATP (oATP) and phorbol 12-myristate
13-acetate (PMA) were purchased from Sigma-Aldrich (St. Louis,
MO). Human caspase-1 inhibitor (Z-YVAD-fmk), and (2R, 4R)-4-
Aminopyrrolidine-2,4-dicarboxylic acid (APDC) were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA). Cathepsin B
inhibitor (CA-074-Me) was purchased from Calbiochem (La Jolla,
CA). Cell culture medium (RPMI 1640), FBS, penicillin and
streptomycin were purchased from Gibco BRL (Grand Island,
NY). For Western blot analysis, the antibodies against IL-1b was
from Cell Signaling Technology (Beverly, MA); against ASC and
pro-IL-1b, from Santa Cruz Biotechnology; against NLRP3, from
Sigma-Aldrich; against caspase-1, from Millipore (Billerica, MA);
and against b-actin, from Novus Biologicals (Littleton, CO). The
secondary antibodies were horseradish peroxidase-conjugated
anti-rabbit and anti-mouse IgGs (Santa Cruz Biotechnology).
Preparation of AbM water extract
Water extracts of AbM were obtained from Chang Gung
Biotechnology (Taipei, Taiwan). This mushroom extract is a
commercial product and components of extract were partially
released due to business confidential. The AbM mycelia powder
contains per 100 g the following constituents: fat 0.4860.12 g,
sodium 66616.5 mg, carbohydrate 49.6612.4 g, protein
19.764.9 g, ash 6.4861.62 g, sugars ,16 g, ergosterol
.0.039 g, b-glucan .7.62 g, water-soluble polysaccharide
.11 g, and moisture ,5%. Briefly, the AbM water extract was
first prepared by adding 400 g of AbM mycelia powder and
10 liters of distilled water into New Brunswick Scientific BioFlo
4500 fermentor (Edison, NJ) and stirred at 121uC for 30 min with
a speed of 150 rpm. The AbM mycelia extract was cooled to room
temperature and subsequently, centrifuged at 4500 rpm for
30 min. The supernatants were collected and concentrated to a
final volume of 2 liters by Buchi R220 vacuum concentrator
Figure 8. Schematic model for AbM-induced NLRP3 inflammasome activation and IL-1b secretion in human macrophages. AbM
treatment resulted in ATP release and autocrine P2X7R activation, followed by release of cathepsin B from lysosomes, efflux of K
+, and production of
ROS. The multiple downstream pathways activated the NLRP3 inflammasome, triggering caspase-1 activation and the secretion of IL-1b.
doi:10.1371/journal.pone.0041383.g008
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(Zurich, Switzerland) at 65uC. The AbM extract was finally
subjected to sterilize at 121uC for 20 min, pass by a 0.45 mm filter
(Millipore), and store in dark glass bottles at 220uC until use. The
amount per milliliter of the AbM extract was water-soluble
polysaccharide 76 mg, adenosine 2 mg, protein 21 mg, carbohy-
drate 30 mg, and ash 8 mg.
Cell culture and treatments
THP-1 (American Type Culture Collection, TIB-202), a human
acute monocytic leukemia cell line, were cultured in RPMI 1640
medium supplemented with 10% (v/v) heated-inactivated FBS
and 100 units/ml penicillin and 100 mg/ml streptomycin. THP-1
cells were incubated at 37uC in a 5% CO2 incubator with
saturated humidity. For experiments, cells were plated in 6-well
plates at 26106 cells per well. The cells were differentiated to
adherent macrophages by overnight culture in complete medium
supplemented with 500 ng/ml PMA, and then with fresh
complete medium for an additional 2 days. THP-1 derived
macrophages were treated with AbM at extract concentrations
from 0.1 to 5% and incubated for 24 h. Cell culture supernatants
were harvested at 14,0006 g, 4uC for 5 min, and the supernatants
were collected and stored at 280uC for cytokine assay. In
addition, cell lysates were resuspended in the lysis buffers for RNA
extraction and for Western blot analysis.
Cell viability assay
Cell viability was determined using a commercial MTT based
in vitro toxicology assay Kit (Sigma-Aldrich), which detects viable
cells colorimetrically based on the purple formazan compound
produced by the viable cells. THP-1 cells were initially seeded in
96-well plates (16105 cells/well) for 24 h. For macrophage
differentiation, cells were treated and incubated with PMA in
the same manner as described above. Cell media were replaced by
complete media containing different concentrations of AbM
extract in a range from 0.1 to 5% and then incubated with cells
for 24 h. After incubation, 10 ml of MTT (5 mg/ml) were added
to each well, and the plates were incubated at 37uC for 4 h. After
incubation, each well was followed by eluting and dissolving the
precipitate with 100 ml of the MTT solubilization solution. Cell
viability was obtained by calculating absorption values at 570 nm
using a VersaMax microplate ELISA reader (Sunyvale, CA). All
treated samples and controls were tested in triplicate.
ELISA
THP-1 macrophages (26106 cells/well) in 6-well culture plates
were treated with AbM extracts in 1 ml of complete medium for
24 h. Cell culture supernatants were harvested as previously
described. Levels of secreted IL-1b and activated caspase-1 in cell
culture supernatants were measured using sandwich enzyme
immuno assays (ELISA). Commercially available ELISA kits for
human IL-1b and caspase-1 were purchased from R&D Systems
(Minneapolis, MN), and were performed according to the
manufacturer’s instructions.
Measurement of ROS production
Total ROS/Superoxide detection kit (Enzo Life sciences,
Farmingdale, NY) was used for assessment of ROS production
in THP-1 macrophages. Briefly, cells were first seeded (16105
cells/well) in 96-well culture plates for 24 h. For macrophage
differentiation, cells were treated and incubated with PMA in the
same manner as described above. Cell media were replaced by
complete media containing different concentrations of AbM
extract (0.1 to 5%) and then incubated for 24 h. In addition, cells
were treated with ROS inducer pyocanin (200 mM), a positive
control, at 37uC for 30 min. After treatment, cells were washed
with 200 ml of 16 wash buffer and loaded with 100 ml of ROS/
Superoxide detection reagents, and then incubated at 37uC for
1 h. Read the plates using a VersaMax microplate ELISA reader
(Sunyvale, CA) at 520 nm after excitation at 488 nm. The increase
in relative fluorescence intensity (RFI) was used to determine
intracellular ROS production.
Western blot analysis
Twenty-four hours after AbM extract treatment, cell extracts
and cell culture supernatants were analyzed by Western blot
analysis. The AbM-treated cells were collected and washed twice
with PBS before incubation in RIPA lysis buffer (50 mM Tris-HCl
(pH 7.4), 150 mM NaCl, 0.25% deoxycholic acid, 1% Nonidet P-
40, 1 mM EDTA) (Millipore) and complete protease inhibitor
cocktail (Roche, Mannheim, Germany) on ice for 30 min. Cell
suspensions were then centrifuged at 15,0006 g, 4uC for 30 min,
and the supernatants of cell suspensions were collected and stored
at 280uC. Total protein concentration in samples was determined
using the Bio-Rad Bradford assay (Herculus, CA). Protein profiles
were separated by electrophoresis in 10 to 15% SDS-polyacryl-
amide gels and transferred onto Millipore PVDF membranes, and
specific proteins were detected by the appropriate primary and
secondary antibodies before visualization using an enhanced
chemiluminescence detection kit (Millipore).
RNA isolation and RT-PCR
Total RNA was extracted from THP-1 cells using total RNA
mini kit, and RNA extraction was followed by the Geneaid’s
instruction (Taipei, Taiwan). Two micrograms of RNA were
reversely transcribed reaction volumes of 20 ml which contains an
oligo (dT) primer (Invitrogen, Carlsbad, CA) and the M-MLV
reverse transcriptase (Promega, Madison, WI). The cDNA for
ASC, IL-1b, NLRP3 and b-actin were amplified by PCR with
specific primers: ASC forward primer 59-ATC-
CAGGCCCCTCCTCAGT-39, and reverse primer 59-
GTTTGTGACCCTCCGCGATAAG-39; IL-1b forward primer
59-AAAAGCTTGGTGATGTCTGG-39, and reverse primer 59-
TTTCAACACGCAGGACAGG-39; NLRP3 forward primer 59-
CTTCTCTGATGAGGCCCAAG-39, and reverse primer 59-
GCAGCAAACTGGAAAGGAAG-39; and b-actin forward prim-
er 59-GAGACCTTCAACACCCCAGCC-39, and reverse primer
59-GGATCTTCATGAGGTAGTCAG-39. The PCR products
were electrophoresed in a 2% agarose gel and visualized by
ethidium bromide staining on an image system.
Generation of THP-1 cells stably expressing shRNA
THP-1 cells stably expressing short hairpin RNA (shRNA)
against ASC, NLRP3, and nontarget control were obtained as
previously described [63]. ASC, NLRP3, and nontarget control
knockdown THP-1 cells were confirmed by RT-PCR and Western
blot analysis. For experiments, cells were either untreated or
treated with AbM extract in the same manner as previously
described. Cell culture supernatants were harvested and stored at
280uC for cytokine assays and Western blot analysis.
Statistical analysis
Triplicate data in each experiment were presented as mean 6
SE. Mean comparisons between AbM extract-untreated control
cells and treated cells were analyzed using Student’s t-test. P values
below 0.05 were considered statistically significant.
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